switching between glp-1 agonists ada Comparing Ozempic, Wegovy and Other Drugs Adjunctive Treatment with GLP-1 and
Description
These actions stem from their ability to suppress pro-inflammatory cytokines, mitigate oxidative stress by reducing reactive oxygen species (ROS), and inhibit neurotoxic astrocyte activation (Athauda and Foltynie, 2016
With regards to specific outcomes such as HF, there has been heterogeneity in the results with both GLP-1RAs and DPP-4i
other hypoglycemics for patients with type 2 diabetes
Bytzer P, Talley NJ, Leemon M, et al
It is rare but serious
TDI, total daily insulin
